Company research / GKOS

Glaukos Corp (GKOS)

SEC name GLAUKOS Corp · CIK 0001192448 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Glaukos Corp reported revenue of $507.44M. Revenue grew 32.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $612.84M.

Key ratios (year ended 2025-12-31)

55.7%
Gross margin
-39.3%
Operating margin
-37.0%
Net margin
-28.6%
Return on year-end equity
32.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-07

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$612.84M$507.44M$383.48M$314.71M$282.86M$294.01M$224.96M$236.98M$181.28M$159.25M$114.40M
Cost of Revenue$127.96M$111.81M$94.03M$75.58M$68.98M$66.63M$91.72M$38.59M$25.07M$21.05M$16.18M
Gross Profit$372.01M$282.76M$289.45M$239.14M$213.88M$227.38M$133.24M$198.40M$156.20M$138.20M$98.22M
R&D Expense$177.17M$150.61M$136.43M$138.77M$123.27M$101.00M$85.39M$68.31M$49.68M$38.91M$29.22M
Operating Income-$193.36M-$199.60M-$122.37M-$128.70M-$82.31M-$32.87M-$123.55M-$50.29M-$13.00M-$2.28M$4.24M
Depreciation & Amortization$41.96M$38.09M$35.65M$33.65M$31.58M$29.66M$29.38M$6.31M$6.26M$5.48M$4.72M
EBITDA-$151.39M-$161.51M-$86.72M-$95.05M-$50.74M-$3.21M-$94.17M-$43.99M-$6.74M$3.20M$8.96M
Net Income-$188.05M-$187.69M-$146.37M-$134.66M-$99.19M-$49.59M-$120.35M$15.42M-$12.95M-$92.0K$4.52M
EPS (Diluted)n/a-$3.28-$2.77-$2.78-$2.09-$1.07-$2.70$0.37-$0.37$0.00$0.12
Total Assets$920.52M$893.49M$974.76M$940.41M$1.00B$1.05B$1.01B$818.40M$206.97M$165.84M$134.37M
Total Liabilities$238.03M$237.33M$207.82M$478.65M$472.38M$462.55M$338.05M$145.13M$33.11M$27.63M$17.10M
Shareholders' Equity$682.49M$656.15M$766.93M$461.77M$530.00M$587.15M$667.45M$673.27M$173.86M$138.20M$117.27M
Cash & Equivalents$114.48M$90.81M$169.63M$93.47M$119.53M$100.71M$96.60M$62.43M$29.82M$24.51M$6.49M
Operating Cash Flow-$950.0K-$14.79M-$61.32M-$57.76M-$33.08M$24.71M-$22.99M-$369.0K$18.86M$26.09M$12.31M
Capital Expenditures$11.25M$7.67M$6.30M$20.25M$30.27M$47.78M$6.93M$4.72M$10.31M$6.31M$6.28M
Free Cash Flow-$12.20M-$22.45M-$67.62M-$78.01M-$63.35M-$23.08M-$29.92M-$5.09M$8.55M$19.78M$6.03M
Shares Outstanding58.86M57.51M56.44M49.12M47.75M46.97M45.25M43.50M36.11M34.62M33.94M
Weighted Average Diluted Sharesn/a57.19M52.76M48.43M47.44M46.42M44.50M41.15M35.32M34.38M36.46M
EPS (Basic)n/a-$3.28-$2.77-$2.78-$2.09-$1.07-$2.70$0.41-$0.37$0.00$0.14

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView